Institut de Terapia Regenerativa Tissular Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2009
NCT01440725
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Institut de Terapia Regenerativa Tissular

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Back Pain (Phase 3)

Hematoma (Phase 3)

Intervertebral Disc Degeneration (Phase 3)

Low Back Pain (Phase 3)

Rupture (Phase 3)

Xerostomia (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 3